AB 1320
10 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
AB 1320
California Affordable Drug Manufacturing Act of 2020: opioid antagonists
California · Failed
Every link on this map
The same connections as a table, with the reason each one is here.
| Joe Patterson | Sponsors | Joe Patterson sponsored AB 1320. | None |
| Association for Accessible Medicines (Aam) | Lobbied on it | Association for Accessible Medicines (Aam) named AB 1320 in 2 lobbying reports. | 2 reports |
| Cencora | Lobbied on it | Cencora named AB 1320 in 2 lobbying reports. | 2 reports |
| Indivior Inc. | Lobbied on it | Indivior Inc. named AB 1320 in 2 lobbying reports. | 2 reports |
| Pharmaceutical Research and Manufacturers of America | Lobbied on it | Pharmaceutical Research and Manufacturers of America named AB 1320 in 2 lobbying reports. | 2 reports |
| Purdue Pharma L.P. | Lobbied on it | Purdue Pharma L.P. named AB 1320 in 2 lobbying reports. | 2 reports |
| Amneal Pharmaceuticals, Inc. | Lobbied on it | Amneal Pharmaceuticals, Inc. named AB 1320 in 1 lobbying report. | 1 report |
| Cardinal Health, Inc. | Lobbied on it | Cardinal Health, Inc. named AB 1320 in 1 lobbying report. | 1 report |
| Drug Policy Alliance | Lobbied on it | Drug Policy Alliance named AB 1320 in 1 lobbying report. | 1 report |
| California Affordable Drug Manufacturing Act of 2020: opioid antagonists. | Source records | AB 1320 has an explicit source reference to California Affordable Drug Manufacturing Act of 2020: opioid antagonists.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…